Dynavax Technologies Corporation (DVAX) NASDAQ

11.26

-0.01(-0.09%)

Updated at November 12 04:00PM

Currency In USD

Valuation

Market Cap1.66B
Enterprise Value1.82B
P/E Ratio-25.48
PEG Ratio-1.78
Price/Sales Ratio4.18
Price/Book Ratio2.72
Enterprise/Revenue4.77
Enterprise/EBITDA-43.65

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.17
Operating Margin-0

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.09

Income Statement

Revenue277.25M
Revenue/Share2.65
Gross Profit227.8M
EBITDA45.7M
Net Income27.31M
Diluted EPS0.2

Balance Sheet

Total Cash647.82M
Total Cash/Share5.14
Total Debt285.02M
Total Debt/Equity0.58
Current Ratio6.65
Book Value Per Share4.14

Price History

52-Week Change-16.72
52-Week High14.63
52-Week Low9.2
Moving Average 50 Days10.09
Moving Average 200 Days11.09

Statistics

Average Volume1.71M
Shares Outstanding117.42M
% Held by Institutions95.95

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateNovember 10, 2014